Voltammetric Determination of Candesartan Cilexetil in Its Cu(II) Complex and Application to Pharmaceutical FormulationsSÜSLÜ, Incilay; ÖZALTIN, Nuran; ALTINÖZ, Sacide et al.Journal of AOAC International. 2010, Vol 93, Num 2, pp 562-568, issn 1060-3271, 7 p.Article

Stability-Indicating Methods for the Determination of Candesartan Cilexetil in Bulk Drug and Pharmaceutical FormulationsISSA, Yousry M; HUSSIEN, Emad M; IBRAHIM, Magda M et al.Journal of AOAC International. 2013, Vol 96, Num 3, pp 580-586, issn 1060-3271, 7 p.Article

Pharmacokinetic- pharmacodynamic interactions of candesartan cilexetil and losartanAZIZI, M; CHATELLIER, G; GUYENE, T.-T et al.Journal of hypertension. 1999, Vol 17, Num 4, pp 561-568, issn 0263-6352Article

Inhibition of angiotensin II pressor response and ex vivo angiotensin II radioligand binding by candesartan cilexetil and losartan in healthy human volunteersBELZ, G. G; FUCHS, B; MALERCZYK, C et al.Journal of human hypertension. 1997, Vol 11, pp S45-S47, issn 0950-9240, SUP2Article

Pharmacokinetic drug interaction studies with candesartan cilexetilJONKMAN, J. H. G; VAN LIER, J. J; VAN HEININGEN, P. N. M et al.Journal of human hypertension. 1997, Vol 11, pp S31-S35, issn 0950-9240, SUP2Article

Angiotensin II antagonism refined: candesartan cilexetil. A novel long-acting selective AT¹ receptor blockerSEVER, P; MENARD, J.Journal of human hypertension. 1997, Vol 11, issn 0950-9240, 97 p., SUP2Serial Issue

Angiotensin receptor gene expression in candesartan mediated neuroprotectionQING LU; ZHU, Yi-Zhun; WONG, Peter T.-H et al.Neuroreport (Oxford). 2004, Vol 15, Num 17, pp 2643-2646, issn 0959-4965, 4 p.Article

Efficacité et tolérance du candésartan cilexetil 16 mg associé à 12,5 mg d'hydrochlorothiazide chez les patients présentant une hypertension artérielle essentielle non équilibrée par une association fixeVAÏSSE, B.La Lettre du cardiologue. 2004, Num 377, pp 32-35, issn 0761-5035, 4 p.Article

Synthesis of deuterium-labeled olmesartan and candesartanCHI ZHANG; ZUCHENG SHEN; LEI TIAN et al.Journal of labelled compounds & radiopharmaceuticals. 2012, Vol 55, Num 11-12, pp 401-405, issn 0362-4803, 5 p.Article

Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice : the SARA studyBARRIOS, Vivencio; CALDERON, Alberto; ESCOBAR, Carlos et al.Journal of hypertension. 2007, Vol 25, Num 9, pp 1967-1973, issn 0263-6352, 7 p.Article

Candesartan cilexetil : An angiotensin II-receptor blockerSEE, S; STIRLING, A. L.American journal of health-system pharmacy. 2000, Vol 57, Num 8, pp 739-746, issn 1079-2082Article

Efficacité du candesartan cilexetil chez les hypertendus diabétiques ou non diabétiques = Efficacy of candesartan cilexetil in hypertensive patients with or without diabetesEL FEGHALI, R; NISSE-DURGEAT, S; ASMAR, R et al.Archives des maladies du coeur et des vaisseaux. 2007, Vol 100, Num 8, pp 679-682, issn 0003-9683, 4 p.Conference Paper

Solubility of Candesartan Cilexetil in Different Solvents at Various TemperaturesPENGLEI CUI; QIUXIANG YIN; JUNBO GONG et al.Journal of chemical and engineering data (Print). 2011, Vol 56, Num 3, pp 658-660, issn 0021-9568, 3 p.Article

Efficacité du candésartan cilexétil chez les patients hypertendus diabétiques ou non. Méta-analyse des études cliniques randomisées en double aveugleLAVERGNE, A.La Lettre du cardiologue. 2007, Num 406, pp 38-40, issn 0761-5035, 3 p.Article

A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan : CLAIM Study IIVIDT, D. G; WHITE, W. B; RIDLEY, E et al.Journal of human hypertension. 2001, Vol 15, Num 7, pp 475-480, issn 0950-9240Article

Angiotensin II type 1 receptor blockersBURNIER, Michel.Circulation (New York, N.Y.). 2001, Vol 103, Num 6, pp 904-912, issn 0009-7322Article

Candesartan cilexetil and renal hemodynamics in hypertensive patientsFRIDMAN, K; WYSOCKI, M; FRIBERG, P et al.American journal of hypertension. 2000, Vol 13, Num 9, pp 1045-1048, issn 0895-7061Article

Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertensionOPARIL, S.The American journal of cardiology. 1999, Vol 84, Num 10A, pp 35S-41S, issn 0002-9149Article

Comparison of angiotensin II receptor blockers: Impact of missed doses of candesartan cilexetil and losartan in systemic hypertensionMANCIA, G; DELL'ORO, R; TURRI, C et al.The American journal of cardiology. 1999, Vol 84, Num 10A, pp 28S-34S, issn 0002-9149Article

Do pharmacologic differences among antihypertensive agents point to clinical benefits?MEREDITH, P.The American journal of cardiology. 1999, Vol 84, Num 10A, pp 22S-27S, issn 0002-9149Article

A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertensionANDERSSON, O. K; NELDAM, S.Journal of human hypertension. 1997, Vol 11, pp S63-S64, issn 0950-9240, SUP2Article

Thermodynamic analysis and correlation of solubility of candesartan cilexetil in aqueous solvent mixturesPENGLEI CUI; QIUXIANG YIN; JUNBO GONG et al.Fluid phase equilibria. 2013, Vol 337, pp 354-362, issn 0378-3812, 9 p.Article

The data monitoring experience in the Candesartan in Heart Failure Assessment of Reduction in Mortality and morbidity (CHARM) programPOCOCK, Stuart; DUOLAO WANG; WILHELMSEN, Lars et al.The American heart journal. 2005, Vol 149, Num 5, pp 939-943, issn 0002-8703, 5 p.Article

A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapyCAMPBELL, M; SONKODI, S; SOUCEK, M et al.Clinical and experimental hypertension (1993). 2001, Vol 23, Num 4, pp 345-355, issn 1064-1963Article

A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonistsVAUQUELIN, Georges; MORSING, Peter; FIERENS, Frederik L. P et al.Biochemical pharmacology. 2001, Vol 61, Num 3, pp 277-284, issn 0006-2952Article